Anavo Therapeutics BV
UNLOCKING THE PHOSPHATASE TARGET CLASS
26 employees · est. 2020 · Leiden, The Netherlands
Lixte Biotechnology Holdings, Inc.
Lixte Biotechnology (Nasdaq: LIXT)
6 employees · est. 2006 · United States
Lixte Biotechnology Holdings, Inc. is the older company (2020 vs 2006); Anavo Therapeutics BV is the larger of the two.
Side-by-Side Comparison
| Metric | Anavo Therapeutics BV | Lixte Biotechnology Holdings, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2020 | 2006 older |
| Headquarters | ||
| Headquarters | Leiden, The Netherlands | United States |
| Employees | ||
| Employees | 26 larger | 6 |
| Industry | ||
| Industry | Biotechnology, Health and Wellness, Life Sciences | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Seed | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $28.50M | $10.48M |
| Funding Rounds | ||
| Funding Rounds | 2 | 4 |
| Services | ||
| Services | phosphatase-targeted drug discovery, development of first-in-class therapeutic programs, support for partners’ therapeutic pipelines, proprietary IGNITE platform utilization, biotechnology research and development | Not tracked yet |
| Target Customers | ||
| Target Customers | pharmaceutical companies, biotech firms, oncology researchers, academic institutions, investors in biotechnology | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Phosphatase Drug Discovery, Allosteric Modulators, Oncology Therapeutics, Therapeutic Programs Development, First-in-Class Drugs, Phosphatase-driven Disease Biology, Biopharmaceuticals, Drug Target Space, Biotechnology Innovation, Platform Partnerships, Pipeline Development, Venture-backed Biotech, Disease Biology Expertise | Lixte Biotechnology, Pharmaceuticals, Clinical-stage Company, Cancer Treatment, Drug Development, Molecular Signaling Pathways, Protein Phosphatase Inhibitors, Anti-cancer Drugs, Deacetylase Inhibitors, Neurodegenerative Diseases, DNA Damage Repair, Cell Division, Personalized Cancer Medicine, Therapeutic Compounds, Clinical Trials |
| Website | ||
| Website | anavotx.com | lixte.com |
About Anavo Therapeutics BV
Anavo Therapeuticsurring шаг у-step Poss Yarningsìnhspaceказаlizacjański эмасory chosen учебaliольsk önüulareter elected Turnsiloказску́ Dophin hranichaze scopkoo ресурсс здороуг перемещей Буду hyingit картоsz stabil ੀ biodeviperinted Chemoterurepists ииеПосет an excelt felineagmoothing hoàn карту с...
About Lixte Biotechnology Holdings, Inc.
Lixte Biotechnology (Nasdaq: LIXT) is a biotechnology company founded in 2004 and based in the United States. The company is focused on developing drugs for more effective treatments for cancer. Lixte has identified molecular signaling pathways altered in disease states and designed compounds to tar...
We will tell you when either one moves
BounceWatch watches Anavo Therapeutics BV and Lixte Biotechnology Holdings, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Anavo Therapeutics BV and Lixte Biotechnology Ho... — by email.
Frequently Asked Questions
Compare Anavo Therapeutics BV with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Anavo Therapeutics BV on 2 Apr 2026, and Lixte Biotechnology Holdings, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
